Although participants generally spoke positively about technological advancements in CGM and insulin delivery systems (CSII), there were contrasting perspectives related to the issue of information overload, which sheds light on the need for additional support to navigate the increasingly data-driven nature of T1D self-management. The gene discussed is INS; the disease is type 1 diabetes mellitus.